Managing Oncology Drug Costs
As the cost of cancer drugs increases and is in the national spotlight, many cancer program leaders are rightfully concerned about minimizing unnecessary costs and maximizing revenues. To ensure their financial sustainability and improve patients' financial experience, cancer programs must employ a diverse array of strategies to mitigate the risk of increasingly expensive drugs. This session will discuss industry responses to drug costs, teach you tactics for maximizing profitability, and highlight best-in-class organizations.
Things You’ll Learn:
- Explore trends in oncology drug costs
- Understand the implications of rising drug costs for cancer programs' financial health
- Learn strategies to mitigate drug costs--from improving prior authorization to exploring use of biosimilars to standardizing care